Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MMP20 antisense RNA 1 (MMP20-AS1)
- Target
- MMP20-AS1
- Molecular classification
- Other (antisense long non-coding RNA, lncRNA)
01
Overview
MMP20 antisense RNA 1 (MMP20-AS1, also known as AP000851.1) is a long non-coding RNA (lncRNA) gene located in the human genome and expressed as an antisense transcript relative to the MMP20 gene. As an antisense lncRNA, it does not encode a protein and is presumed to act through potential regulatory mechanisms affecting gene expression, mRNA stability, or chromatin state of the sense gene (MMP20), which encodes the matrix metalloproteinase 20 enzyme. However, no specific biological functions, disease associations, or therapeutic relevance have yet been established for MMP20-AS1 itself. *Note:* The presence and basic annotation of this lncRNA are confirmed in public gene resources, but as of now, there is no evidence that it is a characterized therapeutic target, a biomarker, or associated with drugs or defined clinical safety profiles.
- Other names
- AP000851.1
02
Mechanism of action
None reported (no drugs are known to target MMP20-AS1 directly).
03
Biological functions
There is currently no directly documented biological function specifically attributed to MMP20 antisense RNA 1 (MMP20-AS1) in available genetic or functional annotation databases.By analogy to other antisense lncRNAs, possible functions may include: Regulation of expression of its sense gene (MMP20)Potential involvement in mRNA stability or chromatin modification (based on common mechanisms of antisense lncRNAs, but not directly evidenced for MMP20-AS1)
04
Disease associations
No direct disease association documented for MMP20-AS1 itself in current literature or genetic disease resources.Generally, antisense lncRNAs have been implicated in cancer and other diseases, but this has not been specifically shown for MMP20-AS1.
Beyond the preview
Go deeper on MMP20 antisense RNA 1 (MMP20-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MMP20 antisense RNA 1 (MMP20-AS1).